Drugs / VI-1121
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01428362 | Aug 2011 → Aug 2013 | Alzheimer disease | VIVUS LLC | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VI-1121 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01428362 ↗ |